Concepta appoints Penelope McCormick as CEO

(Sharecast News) - British healthcare firm Concepta appointed Penelope McCormick as its chief executive officer on Thursday.
Concepta said it chose McCormick, whose appointment came just 24 hours after the departure of chairman Matthew Walls, due to her commercial leadership experience in the medical devices and women's healthcare sectors.

McCormick previously led BBI Healthcare, where her primary focus was developing a commercial strategy to secure the market-leading position for 'Balance Activ', the company's flagship bacterial vaginosis treatment.

This included the securing of a multi-million pound licence agreement with Bayer, the integration of a newly-acquired Swedish manufacturing facility and portfolio expansion to champion the category growth of women's 'over-the-counter' healthcare within UK retail.

During her 12-year tenure at the BBI Group, McCormick also saw the delivery of a global marketing and integration strategy across the group's various entities through a rapid growth phase, and delivered strong financial growth, market impact and developed skilled teams across the over-the-counter and business-to-business markets in "highly competitive and margin-driven regulated markets".

As of 0940 BST, Concepta shares were down 3.50% at 1.93p.